We further demonstrated that EZH2-mediated epigenetic silencing of miR-29b or miR-30d reprogrammed the expression of LOXL4, which influenced cell proliferation and metastasis in the progression of breast cancer. The gene discussed is LOXL4; the disease is breast carcinoma.